TT
TRIMTECH Therapeutics
United Kingdom · Biotech
Develops small molecule therapies to degrade protein aggregates in neurodegenerative diseases
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Seed+ | $47M | BGF — Role not disclosedCambridge Enterprise Ventures — Role not disclosedCambridge Innovation Capital — Role not disclosedDDF — Role not disclosedEli Lilly and Company — Role not disclosedInc. — Role not disclosedJohnson & Johnson Innovation – JJDC — Role not disclosedMP Healthcare Venture Management — Role not disclosedM Ventures — Role not disclosedPfizer Ventures — Role not disclosedStart Codon — Role not disclosed |